CAMP logo

CAMP4 Therapeutics (CAMP) Cash From Operations

Annual CFO

-$44.16 M
NaN%

December 1, 2023


Summary


Performance

CAMP Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

Quarterly CFO

-$34.27 M
NaN%

September 1, 2024


Summary


Performance

CAMP Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

TTM CFO

-$34.27 M
NaN%

September 1, 2024


Summary


Performance

CAMP TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CAMP Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.6%-579.8%-596.3%
3 y3 years-254.5%-238.5%+15.1%
5 y5 years-192.5%-908.0%-219.9%

CAMP Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-254.5%at low-579.8%at low-553.7%+15.1%
5 y5-year-192.5%at low-430.4%at low-205.2%+15.1%
alltimeall time-166.0%at low-210.9%at low-139.4%+15.1%

CAMP4 Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$34.27 M(+5.9%)
-$34.27 M(+34.6%)
Dec 2023
-$44.16 M(+14.6%)
-
-
Sep 2023
-
-$32.37 M(-553.2%)
-$25.47 M(-468.8%)
Aug 2023
-
$7.14 M(-339.7%)
$6.91 M(-166.6%)
May 2023
-
-$2.98 M(+173.1%)
-$10.36 M(-54.8%)
Feb 2023
-
-$1.09 M(-128.5%)
-$22.93 M(-21.9%)
Dec 2022
-$38.54 M(+813.8%)
-
-
Nov 2022
-
$3.83 M(-137.9%)
-$29.37 M(-27.2%)
Aug 2022
-
-$10.13 M(-34.9%)
-$40.34 M(+103.3%)
May 2022
-
-$15.55 M(+106.5%)
-$19.85 M(+370.5%)
Feb 2022
-$4.22 M(-114.8%)
-$7.53 M(+5.5%)
-$4.22 M(-155.8%)
Nov 2021
-
-$7.14 M(-168.8%)
$7.55 M(-69.7%)
Aug 2021
-
$10.37 M(>+9900.0%)
$24.91 M(+9.7%)
May 2021
-
$78.00 K(-98.2%)
$22.72 M(-20.5%)
Feb 2021
$28.59 M(+147.6%)
$4.24 M(-58.5%)
$28.59 M(-12.3%)
Nov 2020
-
$10.22 M(+25.0%)
$32.58 M(+25.1%)
Aug 2020
-
$8.18 M(+37.7%)
$26.05 M(+13.1%)
May 2020
-
$5.94 M(-27.9%)
$23.04 M(+99.6%)
Feb 2020
$11.54 M(-75.8%)
$8.24 M(+123.8%)
$11.54 M(+291.3%)
Nov 2019
-
$3.68 M(-28.8%)
$2.95 M(-72.0%)
Aug 2019
-
$5.17 M(-193.2%)
$10.53 M(-6.6%)
May 2019
-
-$5.55 M(+1472.8%)
$11.28 M(-76.4%)
Feb 2019
$47.74 M(-28.6%)
-$353.00 K(-103.1%)
$47.74 M(-15.1%)
Nov 2018
-
$11.26 M(+90.2%)
$56.26 M(-16.9%)
Aug 2018
-
$5.92 M(-80.8%)
$67.72 M(-22.1%)
May 2018
-
$30.91 M(+278.7%)
$86.90 M(+29.9%)
Feb 2018
$66.89 M(+159.3%)
$8.16 M(-64.1%)
$66.89 M(+3.3%)
Nov 2017
-
$22.72 M(-9.5%)
$64.73 M(+52.4%)
Aug 2017
-
$25.10 M(+130.1%)
$42.49 M(+49.7%)
May 2017
-
$10.91 M(+81.8%)
$28.38 M(+10.0%)
Feb 2017
$25.80 M(-45.6%)
$6.00 M(+1152.8%)
$25.80 M(-12.0%)
Nov 2016
-
$479.00 K(-95.6%)
$29.32 M(-22.7%)
Aug 2016
-
$10.99 M(+32.1%)
$37.95 M(-3.7%)
May 2016
-
$8.32 M(-12.7%)
$39.39 M(-16.9%)
Feb 2016
$47.40 M(+65.5%)
$9.53 M(+4.6%)
$47.40 M(+5.2%)
Nov 2015
-
$9.11 M(-26.7%)
$45.06 M(+9.0%)
Aug 2015
-
$12.43 M(-23.8%)
$41.34 M(+9.8%)
May 2015
-
$16.33 M(+127.2%)
$37.64 M(+31.4%)
Feb 2015
$28.64 M(+25.5%)
$7.19 M(+33.3%)
$28.64 M(+15.2%)
Nov 2014
-
$5.39 M(-38.3%)
$24.87 M(-0.8%)
Aug 2014
-
$8.73 M(+19.1%)
$25.07 M(+2.9%)
May 2014
-
$7.33 M(+115.0%)
$24.36 M(+6.8%)
Feb 2014
$22.82 M(+37.5%)
$3.41 M(-39.0%)
$22.82 M(-9.4%)
Nov 2013
-
$5.59 M(-30.3%)
$25.18 M(+8.5%)
Aug 2013
-
$8.03 M(+38.8%)
$23.20 M(+20.9%)
May 2013
-
$5.78 M(+0.2%)
$19.19 M(+15.6%)
Feb 2013
$16.60 M(+33.5%)
$5.77 M(+59.7%)
$16.60 M(+5.3%)
Nov 2012
-
$3.62 M(-9.9%)
$15.76 M(+10.6%)
Aug 2012
-
$4.01 M(+25.6%)
$14.25 M(+6.9%)
May 2012
-
$3.19 M(-35.2%)
$13.33 M(+7.2%)
Feb 2012
$12.43 M(+1350.6%)
$4.93 M(+134.0%)
$12.43 M(+64.7%)
Nov 2011
-
$2.11 M(-31.8%)
$7.55 M(+21.6%)
Aug 2011
-
$3.09 M(+34.4%)
$6.21 M(+74.7%)
May 2011
-
$2.30 M(+4409.8%)
$3.55 M(+314.7%)
Feb 2011
$857.00 K(-67.0%)
$51.00 K(-93.4%)
$857.00 K(-188.5%)
Nov 2010
-
$768.00 K(+76.6%)
-$968.00 K(+6.8%)
Aug 2010
-
$435.00 K(-209.6%)
-$906.00 K(-155.7%)
May 2010
-
-$397.00 K(-77.6%)
$1.63 M(-37.3%)
Feb 2010
$2.60 M(-81.1%)
-$1.77 M(-313.7%)
$2.60 M(-82.6%)
Nov 2009
-
$830.00 K(-72.0%)
$14.88 M(-10.3%)
Aug 2009
-
$2.97 M(+420.9%)
$16.59 M(+32.5%)
May 2009
-
$570.00 K(-94.6%)
$12.52 M(-9.0%)
Feb 2009
$13.76 M(-1032.2%)
$10.51 M(+314.2%)
$13.76 M(+130.8%)
Nov 2008
-
$2.54 M(-330.4%)
$5.96 M(+344.3%)
Aug 2008
-
-$1.10 M(-160.7%)
$1.34 M(+6000.0%)
May 2008
-
$1.81 M(-33.1%)
$22.00 K(-101.5%)
Feb 2008
-$1.48 M
$2.71 M(-230.1%)
-$1.48 M(-275.3%)
DateAnnualQuarterlyTTM
Nov 2007
-
-$2.08 M(-13.9%)
$842.00 K(-94.3%)
Aug 2007
-
-$2.42 M(-863.7%)
$14.65 M(+18.9%)
May 2007
-
$317.00 K(-93.7%)
$12.32 M(-26.3%)
Feb 2007
$16.72 M(-25.3%)
$5.03 M(-57.1%)
$16.72 M(-15.2%)
Nov 2006
-
$11.72 M(-346.6%)
$19.71 M(+48.5%)
Aug 2006
-
-$4.75 M(-200.7%)
$13.27 M(-42.3%)
May 2006
-
$4.72 M(-41.1%)
$22.99 M(+2.7%)
Feb 2006
$22.38 M(+78.5%)
$8.02 M(+51.7%)
$22.38 M(+19.1%)
Nov 2005
-
$5.29 M(+6.6%)
$18.80 M(+18.3%)
Aug 2005
-
$4.96 M(+20.5%)
$15.88 M(+22.4%)
May 2005
-
$4.12 M(-7.2%)
$12.98 M(+3.5%)
Feb 2005
$12.54 M(+105.7%)
$4.43 M(+86.7%)
$12.54 M(+68.1%)
Nov 2004
-
$2.38 M(+15.6%)
$7.46 M(-14.3%)
Aug 2004
-
$2.06 M(-44.0%)
$8.71 M(-6.3%)
May 2004
-
$3.67 M(-669.3%)
$9.29 M(+52.5%)
Feb 2004
$6.09 M(+11.2%)
-$645.00 K(-117.8%)
$6.09 M(+150.2%)
Nov 2003
-
$3.62 M(+37.3%)
$2.44 M(-15.2%)
Aug 2003
-
$2.64 M(+455.8%)
$2.87 M(-41.7%)
May 2003
-
$475.00 K(-111.0%)
$4.92 M(-10.1%)
Feb 2003
$5.48 M(-55.5%)
-$4.30 M(-206.0%)
$5.48 M(-60.1%)
Nov 2002
-
$4.06 M(-13.5%)
$13.72 M(+14.9%)
Aug 2002
-
$4.69 M(+355.5%)
$11.95 M(+12.6%)
May 2002
-
$1.03 M(-73.9%)
$10.61 M(-13.8%)
Feb 2002
$12.31 M(+64.0%)
$3.94 M(+72.9%)
$12.31 M(-15.7%)
Nov 2001
-
$2.28 M(-32.1%)
$14.61 M(+29.0%)
Aug 2001
-
$3.36 M(+22.8%)
$11.32 M(+14.6%)
May 2001
-
$2.73 M(-56.2%)
$9.88 M(+31.6%)
Feb 2001
$7.51 M(+821.3%)
$6.24 M(-721.3%)
$7.51 M(+320.4%)
Nov 2000
-
-$1.00 M(-152.5%)
$1.79 M(+12.3%)
Aug 2000
-
$1.91 M(+425.0%)
$1.59 M(-70.4%)
May 2000
-
$364.00 K(-29.3%)
$5.38 M(+560.0%)
Feb 2000
$815.00 K(-86.3%)
$515.00 K(-142.9%)
$815.00 K(-66.5%)
Nov 1999
-
-$1.20 M(-121.1%)
$2.44 M(-58.3%)
Aug 1999
-
$5.70 M(-235.7%)
$5.83 M(+990.7%)
May 1999
-
-$4.20 M(-296.7%)
$535.00 K(-91.0%)
Feb 1999
$5.93 M(+97.8%)
$2.13 M(-3.0%)
$5.93 M(+21.1%)
Nov 1998
-
$2.20 M(+450.0%)
$4.90 M(+8.9%)
Aug 1998
-
$400.00 K(-66.7%)
$4.50 M(+7.1%)
May 1998
-
$1.20 M(+9.1%)
$4.20 M(+40.0%)
Feb 1998
$3.00 M(-156.6%)
$1.10 M(-38.9%)
$3.00 M(+30.4%)
Nov 1997
-
$1.80 M(+1700.0%)
$2.30 M(-276.9%)
Aug 1997
-
$100.00 K(>+9900.0%)
-$1.30 M(-51.9%)
May 1997
-
$0.00(-100.0%)
-$2.70 M(-49.1%)
Feb 1997
-$5.30 M(-151.5%)
$400.00 K(-122.2%)
-$5.30 M(+65.6%)
Nov 1996
-
-$1.80 M(+38.5%)
-$3.20 M(<-9900.0%)
Aug 1996
-
-$1.30 M(-50.0%)
$0.00(-100.0%)
May 1996
-
-$2.60 M(-204.0%)
$5.90 M(-42.7%)
Feb 1996
$10.30 M(+202.9%)
$2.50 M(+78.6%)
$10.30 M(+32.1%)
Nov 1995
-
$1.40 M(-69.6%)
$7.80 M(-1.3%)
Aug 1995
-
$4.60 M(+155.6%)
$7.90 M(+125.7%)
May 1995
-
$1.80 M(>+9900.0%)
$3.50 M(+2.9%)
Feb 1995
$3.40 M(>+9900.0%)
$0.00(-100.0%)
$3.40 M(0.0%)
Nov 1994
-
$1.50 M(+650.0%)
$3.40 M(+78.9%)
Aug 1994
-
$200.00 K(-88.2%)
$1.90 M(+11.8%)
May 1994
-
$1.70 M(+41.7%)
$1.70 M(-26.1%)
Feb 1994
$0.00(-100.0%)
-
-
Feb 1993
$2.30 M(+53.3%)
$1.20 M(-400.0%)
$2.30 M(+109.1%)
Nov 1992
-
-$400.00 K(-128.6%)
$1.10 M(-26.7%)
Aug 1992
-
$1.40 M(+1300.0%)
$1.50 M(+650.0%)
May 1992
-
$100.00 K(0.0%)
$200.00 K(-60.0%)
Feb 1992
$1.50 M(+400.0%)
-
-
Aug 1991
-
$100.00 K(-133.3%)
$500.00 K(+66.7%)
May 1991
-
-$300.00 K(-133.3%)
$300.00 K(0.0%)
Feb 1991
$300.00 K(+50.0%)
$900.00 K(-550.0%)
$300.00 K(-150.0%)
Nov 1990
-
-$200.00 K(+100.0%)
-$600.00 K(+50.0%)
Aug 1990
-
-$100.00 K(-66.7%)
-$400.00 K(+33.3%)
May 1990
-
-$300.00 K
-$300.00 K
Feb 1990
$200.00 K
-
-

FAQ

  • What is CAMP4 Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics annual CFO year-on-year change?
  • What is CAMP4 Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics quarterly CFO year-on-year change?
  • What is CAMP4 Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics TTM CFO year-on-year change?

What is CAMP4 Therapeutics annual cash flow from operations?

The current annual CFO of CAMP is -$44.16 M

What is the all time high annual CFO for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high annual cash flow from operations is $66.89 M

What is CAMP4 Therapeutics annual CFO year-on-year change?

Over the past year, CAMP annual cash flow from operations has changed by -$5.61 M (-14.56%)

What is CAMP4 Therapeutics quarterly cash flow from operations?

The current quarterly CFO of CAMP is -$34.27 M

What is the all time high quarterly CFO for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high quarterly cash flow from operations is $30.91 M

What is CAMP4 Therapeutics quarterly CFO year-on-year change?

Over the past year, CAMP quarterly cash flow from operations has changed by -$41.42 M (-579.83%)

What is CAMP4 Therapeutics TTM cash flow from operations?

The current TTM CFO of CAMP is -$34.27 M

What is the all time high TTM CFO for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high TTM cash flow from operations is $86.90 M

What is CAMP4 Therapeutics TTM CFO year-on-year change?

Over the past year, CAMP TTM cash flow from operations has changed by -$41.18 M (-596.29%)